ABACAVIR 300 MG TABLET

abacavir sulfate
$0.6586per EA

Strength

300 mg/1

NDC

51079020406

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ABACAVIR SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091294

On Market Since

8/1/2012

Pharmacological Classes

Cytochrome P450 1A1 Inhibitors
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

+1.0%

3M

+4.4%

6M

+2.1%

1Y

+3.5%

3Y

+10.4%

5Y

-13.1%

All

-86.4%